Foundry Partners, LLC - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 320 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.43 and the average weighting 1.3%.

Quarter-by-quarter ownership
Foundry Partners, LLC ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$4,038,000
-48.2%
35,135
-29.6%
0.33%
-54.0%
Q3 2014$7,794,000
+23.2%
49,885
-2.7%
0.72%
+23.2%
Q2 2014$6,324,000
+1485.0%
51,265
+1229.8%
0.59%
+1483.8%
Q1 2014$399,0003,8550.04%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 300,000$46,872,00024.29%
HealthCor Management, L.P. 935,100$146,100,0007.50%
1492 Capital Management LLC 70,167$10,963,0006.07%
Visium Asset Management, LP 2,301,629$359,607,0005.31%
HWG Holdings LP 39,621$6,190,0004.97%
Riggs Asset Managment Co. Inc. 45,649$7,132,0004.14%
Cardinal Capital Management 49,139$7,677,0003.65%
AMI ASSET MANAGEMENT CORP 213,398$33,341,0003.27%
BENNETT LAWRENCE MANAGEMENT L L C/NY 88,435$13,817,0003.14%
Adamant Biomedical Investments AG 78,210$12,220,0003.05%
View complete list of SALIX PHARMACEUTICALS INC shareholders